Výsledky vyhledávání

Akademický článek

CALS-technology for Production of Dibasic Lead Phosphite in Phosphoric Sludge Utilization

Autor: A. Kvasyuk, E. Koltsova, A. Bessarabov, I. Bulatov, T. Stepanova

Publikováno v: Chemical Engineering Transactions, Vol 29 (2012)

Phosphoric sludge is the most harmful and dangerous of waste of phosphorus-containing substances, and its aggregated volumes, by rough estimates, total millions of tons. Therefore utilization of the that waste is now an acute problem and will bring r

Externí odkaz: https://doaj.org/article/90532c0ca63344bb93cb6cc86df5fb25

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

POS1056 PREDICTORS OF RISK OF ANTI-TNF TREATMENT WITHDRAWAL IN PATIENTS WITH PSORIATIC ARTHRITIS – DATA FROM MOSCOW UNIFIED ARTHRITIS REGISTRY (MUAR)

Autor: K. Lytkina, E. Koltsova, E. Shmidt, G. Lukina, E. Zhilyaev

Publikováno v: Annals of the Rheumatic Diseases. 81:848-849

BackgroundRetention on therapy is the most important integrative indicator of the success of the drug, reflecting both the effectiveness and tolerability and general acceptability of treatment. This indicator can be evaluated with high accuracy in ob

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::da1ae7b2ae0c538200c77fa1cff4aca4
https://doi.org/10.1136/annrheumdis-2022-eular.2939

Zobrazit plný text záznamu

AB0306 PNEUMOCOCCAL VACCINATION REDUCES THE RISK OF RESPIRATORY INFECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TARGETED THERAPY. DATA FROM MOSCOW UNIFIED ARTHRITIS REGISTRY (MUAR)

Autor: E. Zhilyaev, G. Lukina, E. Koltsova, D. Murtazalieva, E. Shmidt, K. Lytkina, A. Shmitko, D. Blagovidov, M. Kostinov

Publikováno v: Annals of the Rheumatic Diseases. 81:1278.2-1279

BackgroundThe incidence of infections, mainly pneumonias, is significantly increased in patients with rheumatoid arthritis (RA). The risk increases more in persons treated with targeted anti-inflammatory drugs (tDMARDs), biological or targeted synthe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5fabec14efc45c5de868c6d3fbb25093
https://doi.org/10.1136/annrheumdis-2022-eular.3801

Zobrazit plný text záznamu

AB0162 PREDICTION OF TREATMENT DISCONTINUATION DUE TO ADVERSE EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS USED BIOLOGICAL DMARDs AND TARGETED SYNTHETIC DMARDs

Autor: E. Koltsova, G. Lukina, E. Shmidt, K. Lytkina, E. Zhilyaev

Publikováno v: Annals of the Rheumatic Diseases. 81:1211.1-1211

BackgroundThe main goal of rheumatoid arthritis (RA) patients therapy is to achieve low activity or remission of the disease (T2T strategy). However, it is sometimes necessary to interrupt effective treatment due to the development of adverse events.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::570fa289fc07e5722f7d555372685c27
https://doi.org/10.1136/annrheumdis-2022-eular.1030

Zobrazit plný text záznamu

AB1475 SERUM LEVELS OF INFLAMMATORY BOWEL DISEASE-SPECIFIC ANTIBODIES IN ANKYLOSING SPONDYLITIS

Autor: E. Aleksandrova, A. Novikov, P. Kulakova, E. Koltsova, A. Klimets, N. Savenkova, E. Volnukhin, A. Kovshik, G. Lukina

Publikováno v: Annals of the Rheumatic Diseases. 81:1843.1-1843

BackgroundAnkylosing spondylitis (AS) is an immune-mediated inflammatory disease of the musculoskeletal system, that is often accompanied with a subclinical intestinal inflammation. Inflammatory bowel diseases (IBD), including, Crohn’s disease (CD)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8a58a3ad7239ae682dd9ed5cf9519928
https://doi.org/10.1136/annrheumdis-2022-eular.2580

Zobrazit plný text záznamu

POS1310 LONG - TERM OUTCOMES IN ADULT PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS

Autor: E. Kiseleva, E. Koltsova, E. Volnukhin, N. Savenkova, A. Klimets, E. Rozochkina, A. Kovshik, G. Lukina

Publikováno v: Annals of the Rheumatic Diseases. 81:993.1-993

BackgroundSystemic juvenile idiopathic arthritis (sJIA) debuts in childhood and persists throughout the patient’s lifetime. Currently there is not enough information about the course and therapeutic approaches in patients who have reached the age o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d5bd05afa64cd86ec256556a9dee4357
https://doi.org/10.1136/annrheumdis-2022-eular.2754

Zobrazit plný text záznamu

AB0403 EVALUATION OF THE SAFETY AND EFFICACY OF 13-VALENT PNEUMOCOCCAL VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS

Autor: G. Lukina, D. Murtazalieva, E. Koltsova, M. Kostinov, A. Shmitko, D. Blagovidov, E. Zhilyaev

Publikováno v: Annals of the Rheumatic Diseases. 81:1330.2-1330

BackgroundRheumatoid arthritis (RA) is accompanied by a significant increase in the risk of infection and serious infections, among which pneumonia occupies a leading place. (1) The use of targeted anti-inflammatory drugs is accompanied by an additio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bd28f4322c0212280cc961b48dfd3a7a
https://doi.org/10.1136/annrheumdis-2022-eular.2530

Zobrazit plný text záznamu

AB0771 Evaluation of the efficacy of inhibitors of tumor necrosis factor alpha for patients with ankylosing spondylitis in real clinical practice

Autor: E. Rozochkina, E. Koltsova, D. Murtazalieva, E. Zhilyaev, E. Koshkarova, G. Lukina

Publikováno v: Annals of the Rheumatic Diseases. 81:1511.3-1512

BackgroundThe question of the comparative efficacy of tumor necrosis factor-alpha (TNF-α) inhibitors is topical today, because the research data that were distributed in random sequence mainly reflect the efficacy of the only specific drug, and the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0ea070a5a5a8684d074c668a85d64fac
https://doi.org/10.1136/annrheumdis-2022-eular.3155

Zobrazit plný text záznamu

FRI0447 THE SURVIVAL OF BIOLOGICS IN PSORIATIC ARTHRITIS – THE FIRST DATA FROM MOSCOW UNIFIED REGISTER OF ARTHRITIS (MUAR)

Autor: K. Lytkina, E. Koltsova, E. Zhilyaev, E. Shmidt, Galina Lukina

Publikováno v: Psoriatic arthritis.

Background Early started therapy of psoriatic arthritis with the goal to achieve minimal disease activity can slow the joint damage progression. Data concerning the persistence of psoriatic arthritis (PsA) patients on biologics in real clinical pract

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::df50f44a9186818d9ae3b169d7df8312
https://doi.org/10.1136/annrheumdis-2019-eular.4335

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání